Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
1.64%
03:39

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
sell
Agenus Inc.

Start price
Target price
Perf. (%)
€1.37
01.05.23
-
01.05.24
-69.70%
02.05.24

Innovative
overvalued
Risky Investment
High risks for its business
ReynadJ 
01.05.23 0%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.23
30.04.23
-
30.04.24
-30.34%
01.05.24

StockNews.com 
30.04.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
30.04.23
-
30.04.24
-
01.05.24

StockNews.com 
30.04.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.55
30.04.23
-
30.04.24
-25.17%
01.05.24

StockNews.com 
30.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.44
30.04.23
-
30.04.24
-70.95%
01.05.24

StockNews.com 
30.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.43
30.04.23
-
30.04.24
-47.00%
01.05.24

StockNews.com 
30.04.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.96
30.04.23
-
30.04.24
-56.86%
01.05.24

StockNews.com 
30.04.23 50%
buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.41
29.04.23
-
29.04.24
10.78%
30.04.24

StockNews.com 
29.04.23 50%
sell
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€2.66
29.04.23
-
29.04.24
-88.01%
30.04.24

StockNews.com 
29.04.23 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€83.00
03.03.24
€180.00
31.05.26
-16.27%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
03.03.24 70%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€2.30
29.10.23
€4.00
30.06.26
247.39%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.10.23 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.91
28.06.23
€7.00
31.01.26
-20.20%
28.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
28.06.23 70%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€3.63
24.04.24
37.50%
25.04.24

Needham & Company LLC 
24.04.23 50%
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€6.35
24.04.24
-5.00%
25.04.24

Needham & Company LLC 
24.04.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
23.04.23
-
23.04.24
-60.39%
24.04.24

StockNews.com 
23.04.23 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.21
22.04.23
-
22.04.24
-22.38%
23.04.24

StockNews.com 
22.04.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
22.04.23
-
22.04.24
-
23.04.24

StockNews.com 
22.04.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%